THOMAS JEFFERSON UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1824-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.jefferson.edu
"Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction.
- Conditions
- Interventions
- First Posted Date
- 2022-12-27
- Last Posted Date
- 2022-12-27
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 120
- Registration Number
- NCT05666492
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
- First Posted Date
- 2022-11-25
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 30
- Registration Number
- NCT05627219
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Palbociclib or Tazemetostat in Combination With CPX-351 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- First Posted Date
- 2022-11-25
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 24
- Registration Number
- NCT05627232
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Nursing-Driven Primary Palliative Care for Urban-Dwelling African Americans With Chronic Lung Disease
- Conditions
- Interventions
- First Posted Date
- 2022-11-09
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 23
- Registration Number
- NCT05611125
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)
- First Posted Date
- 2022-10-31
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- Thomas Jefferson University
- Registration Number
- NCT05600556
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Mobile Intervention to Improve Adherence of Oral Anti-cancer Medications Among Acute Myeloid Leukemia Patients, the txt4AML Study
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Thomas Jefferson University
- Registration Number
- NCT05595135
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Evaluating Navitoclax After Failure of Standard Treatments of Azacitidine or Decitabine and Venetoclax in Patients With Aggressive Myelodysplastic Syndrome
- Conditions
- Interventions
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 6
- Registration Number
- NCT05564650
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Neuroimaging Ancillary Study
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 184
- Registration Number
- NCT05545527
- Locations
- 🇮🇳
Jawaharlal Nehru Medical College, Belgaum, Karnataka, India
COVID Booster in Pregnancy and Lactation
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 200
- Registration Number
- NCT05543993
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
A Chatbot-Powered G8 Screening Intervention to Facilitate Referrals to a Comprehensive Geriatric Assessment Among Older Adults With Cancer
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 100
- Registration Number
- NCT05535140
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States